Key Takeaways
- • Inovia Capital promoted Principal Mia Morisset to partner on its growth investment team, recognizing eight years of tenure since her 2018 join date and her status as an "OG team" member from the firm's first growth fund launch.
- • Inovia's third growth equity fund has raised $365 million USD of its $450 million USD target, with Morisset continuing to deploy capital at the Series B stage and beyond across North America.
- • Morisset's investment track record includes multiple positions in healthtech software firm AlayaCare and leadership of Inovia's travel technology strategy through companies like Guesty, positioning her as a specialized investor in late-stage software opportunities.
- • Inovia established a hard investment thesis requiring all future targets to be either AI-native or AI-enabled, reflecting broader market dynamics where AI-native startups captured 40 percent of software deal value in Canada during 2025.
- • The promotion occurs amid Inovia's expanded capital-raising activity, including a sixth venture fund in progress and a new joint Discovery platform partnership with Northleaf Capital Partners focused on emerging fund managers.
Summary
Inovia Capital announced the promotion of Mia Morisset from Principal to Partner on its growth investment team, marking a significant advancement for one of the firm's earliest team members. Morisset joined Inovia's Montreal office in September 2018 and has maintained a consistent focus on late-stage investment opportunities in North America, making her promotion a recognition of eight years of contribution to the venture capital firm's growth strategy since its first growth fund launch.
Morisset will continue deploying capital through Inovia's third growth equity fund, which has achieved $365 million USD in commitments against a $450 million USD fundraising target. Her investment thesis centers on identifying opportunities at the Series B stage and beyond, with demonstrated success in the healthtech software and travel technology sectors. Her portfolio work includes multiple investments in AlayaCare, a healthtech software platform, and leadership of Inovia's travel tech investment efforts, most notably with Guesty. According to Morisset, "I thought it was fascinating to be part of one of the first growth funds in Canada," reflecting her involvement in building the firm's growth strategy during its early fundraising phase.
The promotion reflects Inovia's strategic positioning in response to evolving market conditions, particularly the acceleration of AI adoption in software investments. Morisset emphasized that every investment target going forward must either be AI-native or have AI-enabled technology, a requirement underscored by Inovia's recent research findings that AI-native startups captured 40 percent of software deal value in Canada during 2025. This directional clarity signals heightened selectivity in the firm's capital deployment approach.
Morisset's advancement occurs during a period of expanded activity at Inovia, including the concurrent fundraising of a sixth venture fund and a newly announced partnership with Northleaf Capital Partners on a joint Discovery platform. The Discovery platform targets emerging venture managers, specifically those operating their first, second, or third funds, though neither firm has disclosed specific investment commitments for the initiative. These developments collectively position Inovia as an active participant in both the growth equity and emerging manager funding landscapes in Canada's venture ecosystem.
Morisset will continue deploying capital through Inovia's third growth equity fund, which has achieved $365 million USD in commitments against a $450 million USD fundraising target. Her investment thesis centers on identifying opportunities at the Series B stage and beyond, with demonstrated success in the healthtech software and travel technology sectors. Her portfolio work includes multiple investments in AlayaCare, a healthtech software platform, and leadership of Inovia's travel tech investment efforts, most notably with Guesty. According to Morisset, "I thought it was fascinating to be part of one of the first growth funds in Canada," reflecting her involvement in building the firm's growth strategy during its early fundraising phase.
The promotion reflects Inovia's strategic positioning in response to evolving market conditions, particularly the acceleration of AI adoption in software investments. Morisset emphasized that every investment target going forward must either be AI-native or have AI-enabled technology, a requirement underscored by Inovia's recent research findings that AI-native startups captured 40 percent of software deal value in Canada during 2025. This directional clarity signals heightened selectivity in the firm's capital deployment approach.
Morisset's advancement occurs during a period of expanded activity at Inovia, including the concurrent fundraising of a sixth venture fund and a newly announced partnership with Northleaf Capital Partners on a joint Discovery platform. The Discovery platform targets emerging venture managers, specifically those operating their first, second, or third funds, though neither firm has disclosed specific investment commitments for the initiative. These developments collectively position Inovia as an active participant in both the growth equity and emerging manager funding landscapes in Canada's venture ecosystem.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.